Optimized tetramer analysis reveals Ly49 promiscuity for MHC ligands

Journal of Immunology

Volumn 191, Issue 11, 2013, Pages 5722-5729

  McFall, Emily ^a   Tu, Megan M ^a   Al Khattabi, Nuha ^a   Tai, Lee Hwa ^b   St Laurent, Aaron S ^b   Tzankova, Velina ^b   Hall, Clayton W ^a   Belanger, Simon ^b   Troke, Angela D ^a   Wight, Andrew ^a   Mahmoud, Ahmad Bakur ^a,c   Zein, Haggag S ^a,d   Rahim, Mir Munir A ^a   Carlyle, James R ^e   Makrigiannis, Andrew P ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c TAIBAH UNIVERSITY   (Saudi Arabia)

^d CAIRO UNIVERSITY   (Egypt)

^e Sunnybrook Health Sciences Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CELL PROTEIN; LIGAND; LY49G RECEPTOR; LY49I RECEPTOR; LY49O RECEPTOR; LY49Q RECEPTOR; LY49V RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MHC I RECEPTOR; RECEPTOR; TETRAMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING ASSAY; CELL STRAIN; CELL STRAIN HEK293; CELL STRAIN MC57G; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING;

EID: 84888363484     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300726     Document Type: Article

References (35)

1. Orange, J. S. 2006. Human natural killer cell deficiencies. Curr. Opin. Allergy Clin. Immunol. 6: 399-409.
2. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
3. Raulet, D. H., R. E. Vance, and C. W. McMahon. 2001. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19: 291-330.
4. Lian, R. H., J. D. Freeman, D. L. Mager, and F. Takei. 1998. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor. J. Immunol. 161: 2301-2306.
5. Mason, L. H., J. Willette-Brown, S. K. Anderson, W. G. Alvord, R. L. Klabansky, H. A. Young, and J. R. Ortaldo. 2003. Receptor glycosylation regulates Ly-49 binding to MHC class I. J. Immunol. 171: 4235-4242.
6. Toyama-Sorimachi, N., Y. Tsujimura, M. Maruya, A. Onoda, T. Kubota, S. Koyasu, K. Inaba, and H. Karasuyama. 2004. Ly49Q, a member of the Ly49 family that is selectively expressed on myeloid lineage cells and involved in regulation of cytoskeletal architecture. Proc. Natl. Acad. Sci. USA 101: 1016-1021.
7. Gays, F., J. G. Aust, D. M. Reid, J. Falconer, N. Toyama-Sorimachi, P. R. Taylor, and C. G. Brooks. 2006. Ly49B is expressed on multiple subpopulations of myeloid cells. J. Immunol. 177: 5840-5851.
8. Makrigiannis, A. P., and S. K. Anderson. 2000. Ly49 gene expression in different inbred mouse strains. Immunol. Res. 21: 39-47.
9. Anderson, S. K., K. Dewar, M. L. Goulet, G. Leveque, and A. P. Makrigiannis. 2005. Complete elucidation of a minimal class I MHC natural killer cell receptor haplotype. Genes Immun. 6: 481-492.
10. Belanger, S., L. H. Tai, S. K. Anderson, and A. P. Makrigiannis. 2008. Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome. Genes Immun. 9: 509-521.
11. McVicar, D. W., and D. N. Burshtyn. 2001. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49. Sci. STKE. 2001: re1.
12. Fernandez, N. C., E. Treiner, R. E. Vance, A. M. Jamieson, S. Lemieux, and D. H. Raulet. 2005. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105: 4416-4423.
13. Kim, S., J. Poursine-Laurent, S. M. Truscott, L. Lybarger, Y. J. Song, L. Yang, A. R. French, J. B. Sunwoo, S. Lemieux, T. H. Hansen, and W. M. Yokoyama. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
14. Bélanger, S., M. M. Tu, M. M. Rahim, A. B. Mahmoud, R. Patel, L. H. Tai, A. D. Troke, B. T. Wilhelm, J. R. Landry, Q. Zhu, et al. 2012. Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice. Blood 120: 592-602.
15. Tormo, J., K. Natarajan, D. H. Margulies, and R. A. Mariuzza. 1999. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 402: 623-631.
16. Matsumoto, N., M. Mitsuki, K. Tajima, W. M. Yokoyama, and K. Yamamoto. 2001. The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand. J. Exp. Med. 193: 147-158.
17. Doucey, M. A., L. Scarpellino, J. Zimmer, P. Guillaume, I. F. Luescher, C. Bron, and W. Held. 2004. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nat. Immunol. 5: 328-336.
18. Back, J., E. L. Malchiodi, S. Cho, L. Scarpellino, P. Schneider, M. C. Kerzic, R. A. Mariuzza, and W. Held. 2009. Distinct conformations of Ly49 natural killer cell receptors mediate MHC class I recognition in trans and cis. Immunity 31: 598-608.
19. Back, J., A. Chalifour, L. Scarpellino, and W. Held. 2007. Stable masking by H-2Dd cis ligand limits Ly49A relocalization to the site of NK cell/target cell contact. Proc. Natl. Acad. Sci. USA 104: 3978-3983.
20. Chalifour, A., L. Scarpellino, J. Back, P. Brodin, E. Devèvre, F. Gros, F. Lévy, G. Leclercq, P. Höglund, F. Beermann, and W. Held. 2009. A role for cis interaction between the inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity 30: 337-347.
21. Makrigiannis, A. P., D. Patel, M. L. Goulet, K. Dewar, and S. K. Anderson. 2005. Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes. Genes Immun. 6: 71-83.
22. Makrigiannis, A. P., A. T. Pau, A. Saleh, R. Winkler-Pickett, J. R. Ortaldo, and S. K. Anderson. 2001. Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J. Immunol. 166: 5034-5043.
23. Tai, L. H., M. L. Goulet, S. Belanger, A. D. Troke, A. G. St-Laurent, A. Mesci, N. Toyama-Sorimachi, J. R. Carlyle, and A. P. Makrigiannis. 2007. Recognition of H-2Kb by Ly49Q suggests a role for class Ia MHC regulation of plasmacytoid dendritic cell function. Mol. Immunol. 44: 2638-2646.
24. Michaëlsson, J., A. Achour, A. Rölle, and K. Kärre. 2001. MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the β2-microglobulin subunit. J. Immunol. 166: 7327-7334.
25. Tai, L. H., M. L. Goulet, S. Belanger, N. Toyama-Sorimachi, N. Fodil-Cornu, S. M. Vidal, A. D. Troke, D. W. McVicar, and A. P. Makrigiannis. 2008. Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC. J. Exp. Med. 205: 3187-3199.
26. Scarpellino, L., F. Oeschger, P. Guillaume, J. D. Coudert, F. Lévy, G. Leclercq, and W. Held. 2007. Interactions of Ly49 family receptors with MHC class I ligands in trans and cis. J. Immunol. 178: 1277-1284.
27. Hanke, T., H. Takizawa, C. W. McMahon, D. H. Busch, E. G. Pamer, J. D. Miller, J. D. Altman, Y. Liu, D. Cado, F. A. Lemonnier, et al. 1999. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11: 67-77.
28. Michaëlsson, J., A. Achour, M. Salcedo, A. Kâse- Sjöström, J. Sundbäck, R. A. Harris, and K. Kärre. 2000. Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers. Eur. J. Immunol. 30: 300-307.
29. Patel, R., S. Bélanger, L. H. Tai, A. D. Troke, and A. P. Makrigiannis. 2010. Effect of Ly49 haplotype variance on NK cell function and education. J. Immunol. 185: 4783-4792.
30. Jonsson, A. H., L. Yang, S. Kim, S. M. Taffner, and W. M. Yokoyama. 2010. Effects of MHC class I alleles on licensing of Ly49A+ NK cells. J. Immunol. 184: 3424-3432.
31. Karlhofer, F. M., R. K. Ribaudo, and W. M. Yokoyama. 1992. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 358: 66-70.
32. Johansson, S., M. Johansson, E. Rosmaraki, G. Vahlne, R. Mehr, M. Salmon-Divon, F. Lemonnier, K. Kärre, and P. Höglund. 2005. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J. Exp. Med. 201: 1145-1155.
33. Ober, R. J., C. G. Radu, V. Ghetie, and E. S. Ward. 2001. Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. Int. Immunol. 13: 1551-1559.
34. Andersen, J. T., M. B. Daba, G. Berntzen, T. E. Michaelsen, and I. Sandlie. 2010. Cross-species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding. J. Biol. Chem. 285: 4826-4836.
35. Bossen, C., K. Ingold, A. Tardivel, J. L. Bodmer, O. Gaide, S. Hertig, C. Ambrose, J. Tschopp, and P. Schneider. 2006. Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J. Biol. Chem. 281: 13964-13971.